Streetbeat News

Products Services

DIA

IWM

NVDA

NVO

QQQ

SPY

VSCO

NVIDIA's stock continues to rise after Mizuho raised its price target. Novo Nordisk's stock gains on positive weight loss data. Victoria's Secret's stock falls following Q4 results. Major indexes, including DIA, IWM, QQQ, and SPY, gain after Powell's testimony.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 6:25 pm

RIVN

Rivian has announced the launch of its new R2 SUV, with a starting price of approximately $45,000. Reservations for the R2 SUV will begin on Thursday.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 6:24 pm

HPQ

HP Inc. announced new services and solutions at the Amplify Partner Conference 2024, including HP WEX, an AI-enabled digital experience platform, and initiatives to extend device life and accelerate a circular economy. These offerings aim to enhance productivity, reduce TCO, and support channel partners in delivering superior work experiences. HP also introduced new Managed Services, simplified support packages, and a partnership with Microsoft to integrate WEX with Copilot for Security.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 6:22 pm

AMD

ARM

AVGO

BOTZ

NVDA

SMH

Mizuho analyst Vijay Rakesh has reiterated a Buy rating on Nvidia, AMD, Broadcom, and Arm Holdings, raising their price targets due to multiple expansion and catalysts ahead. Rakesh highlights Arm's leadership in the mobile CPU space and its accelerating custom silicon roadmap. Nvidia is seen as the biggest near-term AI winner, with AMD and Broadcom also benefiting significantly from the AI boom. Investors can gain exposure to Nvidia through the VanEck Semiconductor ETF (SMH) and the Global X Robotics & Artificial Intelligence ETF (BOTZ). NVDA shares saw a 3.49% increase.

Portfolio Pulse from Anusuya Lahiri

March 07, 2024 | 6:22 pm

RIVN

Rivian shares are trading higher amid the company's R2 launch event, indicating positive investor sentiment towards the event.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 6:21 pm

MSFT

Microsoft Corp's (NASDAQ:MSFT) second Xbox Partner Preview event showcased a variety of third-party games for Xbox and Windows PCs. The event featured gameplay trailers and announcements for upcoming games, including titles from developers like Reflector Entertainment, Joshua Boggs, 11 Bit Studios, RocketRide Games, Frogwares, Square Enix, and Capcom. Notable games mentioned include 'Unknown 9: Awakening', 'Sleight of Hand', 'The Alters', 'Creatures of Ava', 'Griefville: Survive the Nightmare!', 'The Sinking City 2', 'Final Fantasy XIV Online: A Realm Reborn', and 'Kunitsu-Gami: Path of the Goddess'. The event emphasized Microsoft's commitment to enriching its gaming ecosystem with diverse and engaging content.

Portfolio Pulse from Franca Quarneti

March 07, 2024 | 6:20 pm

EADSY

Airbus SE (OTC:EADSY) announced it delivered 49 aircraft to 28 customers in February, with a total of 79 deliveries year-to-date. The company also unveiled its CityAirbus NextGen prototype, a full electric aircraft designed for urban air mobility, which is expected to make its maiden flight later this year. Airbus currently operates 13,724 aircraft globally, including 10,952 single-aisle planes. EADSY shares saw a 0.58% increase to $43.29.

Portfolio Pulse from Nabaparna Bhattacharya

March 07, 2024 | 6:20 pm

LLY

NVO

Cigna Group's subsidiary, Evernorth Health Services, introduced a financial guarantee within its EncircleRx program to provide clients with predictability in covering GLP-1s, aiming to control health plans and employers' expenditures. This initiative includes a cost cap or savings guarantee, enhancing accessibility for patients. Evernorth has agreements with Novo Nordisk and Eli Lilly to cap annual spending increases for weight loss and diabetes drugs at 15%. Cigna also raised its long-term average annual adjusted EPS growth target to 10%-14% and reaffirmed its fiscal year 2024 adjusted EPS guidance.

Portfolio Pulse from Vandana Singh

March 07, 2024 | 6:18 pm

CELZ

Creative Medical Technology Holdings Inc (NASDAQ:CELZ) saw its stock surge after receiving FDA authorization for CELZ-201, a therapy aimed at managing abnormal glucose tolerance and preventing Type 1 diabetes in high-risk individuals. This groundbreaking therapy represents a significant advancement in personalized medicine for diabetes management. Additionally, CELZ received Orphan Drug Designation for CELZ-101, ImmCelz, to prevent allograft rejection in pancreatic islet cell transplantation for Type 1 diabetes patients. CELZ shares rose 34.50% to $6.40.

Portfolio Pulse from Vandana Singh

March 07, 2024 | 6:16 pm

Li Auto Inc (NASDAQ:LI) shares dropped in premarket trading due to reports of declining EV deliveries in China. Bernstein analyst Eunice Lee maintains an Outperform rating with a $52.50 price target, viewing the recent 20% stock decline as a buying opportunity. The decline was attributed to weaker than expected order intake for MEGA, Li Auto's flagship MPV. Despite bullish guidance for 2024 and strong Q4 earnings, market chatter suggests only about 4k non-refundable orders for MEGA, against management's guidance of 5k monthly deliveries and an internal target of over 8k.

Portfolio Pulse from Priya Nigam

March 07, 2024 | 6:00 pm